Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GBS NYSE:IHC OTCMKTS:MRIC NYSE:PHM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGBSGBS$2.14+0.5%$1.63$0.36▼$2.89$31.87M1.32955,325 shs170,540 shsIHCIndependence$57.01$56.93$36.99▼$57.43$841.47M0.7923,210 shs40,135 shsMRICMRI Interventions$0.00$2.01▼$6.28$78.16MN/A63,036 shs51,600 shsPHMPulteGroup$108.72-0.5%$104.20$88.07▼$149.47$21.90B1.292.04 million shs1.94 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGBSGBS0.00%+11.11%0.00%+59.66%-3.06%IHCIndependence0.00%0.00%0.00%0.00%0.00%MRICMRI Interventions0.00%0.00%0.00%0.00%0.00%PHMPulteGroup+0.11%-5.03%+10.84%+15.34%-10.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGBSGBSN/AN/AN/AN/AN/AN/AN/AN/AIHCIndependenceN/AN/AN/AN/AN/AN/AN/AN/AMRICMRI InterventionsN/AN/AN/AN/AN/AN/AN/AN/APHMPulteGroup4.9341 of 5 stars3.33.02.51.94.01.73.8Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGBSGBS 0.00N/AN/AN/AIHCIndependence 3.00BuyN/AN/AMRICMRI Interventions 0.00N/AN/AN/APHMPulteGroup 2.60Moderate Buy$133.6922.97% UpsideCurrent Analyst Ratings BreakdownLatest KMK, IHC, GBS, MRIC, and PHM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/15/2025PHMPulteGroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$125.00 ➝ $132.007/8/2025PHMPulteGroupWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $125.004/23/2025PHMPulteGroupRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$116.00 ➝ $109.004/23/2025PHMPulteGroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$151.00 ➝ $141.004/23/2025PHMPulteGroupEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$161.00 ➝ $165.004/23/2025PHMPulteGroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$100.00 ➝ $98.004/22/2025PHMPulteGroupWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$135.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGBSGBSN/AN/AN/AN/A$0.44 per shareN/AIHCIndependence$443.86M1.90$1.76 per share32.36$32.05 per share1.78MRICMRI InterventionsN/AN/AN/AN/AN/AN/APHMPulteGroup$17.95B1.21$14.16 per share7.68$59.87 per share1.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGBSGBS-$8.31M-$0.56N/AN/AN/AN/A-85.64%-54.42%N/AIHCIndependence$18.88M$7.157.97∞N/A35.00%-0.14%-0.06%N/AMRICMRI InterventionsN/AN/A0.00N/AN/AN/AN/AN/AN/APHMPulteGroup$3.08B$14.187.678.040.3216.45%22.86%15.83%7/22/2025 (Estimated)Latest KMK, IHC, GBS, MRIC, and PHM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025PHMPulteGroup$2.94N/AN/AN/A$4.42 billionN/A4/22/2025Q1 2025PHMPulteGroup$2.47$2.57+$0.10$2.57$3.86 billion$3.89 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGBSGBSN/AN/AN/AN/AN/AIHCIndependence$0.120.21%N/A1.68%N/AMRICMRI InterventionsN/AN/AN/AN/AN/APHMPulteGroup$0.880.81%N/A6.21%7 YearsLatest KMK, IHC, GBS, MRIC, and PHM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2025PHMPulteGroupquarterly$0.220.85%6/17/20256/17/20257/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGBSGBSN/A2.332.33IHCIndependenceN/A1.041.04MRICMRI InterventionsN/AN/AN/APHMPulteGroup0.130.800.80Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGBSGBS2.79%IHCIndependence21.91%MRICMRI InterventionsN/APHMPulteGroup89.90%Insider OwnershipCompanyInsider OwnershipGBSGBS0.27%IHCIndependence6.13%MRICMRI InterventionsN/APHMPulteGroup0.76%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGBSGBS714.89 million14.85 millionNot OptionableIHCIndependence55014.76 million13.86 millionNot OptionableMRICMRI Interventions3815.21 millionN/ANot OptionablePHMPulteGroup6,793200.43 million198.90 millionOptionableKMK, IHC, GBS, MRIC, and PHM HeadlinesRecent News About These CompaniesHow Will PulteGroup Stock React To Its Upcoming Earnings?July 18 at 2:52 PM | forbes.comMystic Asset Management Inc. Acquires New Shares in PulteGroup, Inc. (NYSE:PHM)July 18 at 11:36 AM | marketbeat.comPulteGroup, Inc. (PHM) is Attracting Investor Attention: Here is What You Should KnowJuly 18 at 10:01 AM | zacks.comHere's What Investors Must Know Ahead of PulteGroup's Q2 EarningsJuly 18 at 9:56 AM | zacks.comPatton Albertson Miller Group LLC Sells 11,473 Shares of PulteGroup, Inc. (NYSE:PHM)July 18 at 9:10 AM | marketbeat.comRetirement Planning Co of New England Inc. Invests $406,000 in PulteGroup, Inc. (NYSE:PHM)July 18 at 9:03 AM | marketbeat.comPulteGroup, Inc. (NYSE:PHM) Stake Raised by Kingsview Wealth Management LLCJuly 18 at 8:38 AM | marketbeat.comCerity Partners LLC Has $3.64 Million Stock Holdings in PulteGroup, Inc. (NYSE:PHM)July 18 at 3:54 AM | marketbeat.comCountdown to PulteGroup (PHM) Q2 Earnings: Wall Street Forecasts for Key MetricsJuly 17 at 10:15 AM | zacks.comDel Webb Carolina Overlook Unveils Spectacular 20,000 Square Foot Clubhouse and Introduces New Villa CollectionJuly 17 at 8:13 AM | businesswire.comVictory Capital Management Inc. Buys 284,627 Shares of PulteGroup, Inc. (NYSE:PHM)July 17 at 6:51 AM | marketbeat.comPulteGroup's (PHM) Outperform Rating Reaffirmed at OppenheimerJuly 17 at 2:37 AM | americanbankingnews.comPulteGroup (PHM) Outperforms Broader Market: What You Need to KnowJuly 16 at 6:46 PM | zacks.comWealthfront Advisers LLC Purchases 4,850 Shares of PulteGroup, Inc. (NYSE:PHM)July 16 at 6:44 AM | marketbeat.comPulteGroup (NYSE:PHM) Price Target Raised to $132.00July 15 at 11:37 AM | marketbeat.comConcord Asset Management LLC VA Buys 2,255 Shares of PulteGroup, Inc. (NYSE:PHM)July 15 at 8:52 AM | marketbeat.comWinslow Asset Management Inc. Sells 6,064 Shares of PulteGroup, Inc. (NYSE:PHM)July 15 at 8:32 AM | marketbeat.comPrevail Innovative Wealth Advisors LLC Invests $3.94 Million in PulteGroup, Inc. (NYSE:PHM)July 15 at 6:53 AM | marketbeat.comEnvestnet Asset Management Inc. Purchases 2,930 Shares of PulteGroup, Inc. (NYSE:PHM)July 15 at 3:36 AM | marketbeat.comPulteGroup (PHM) Projected to Post Quarterly Earnings on TuesdayJuly 15 at 2:21 AM | marketbeat.comEdgestream Partners L.P. Buys 74,536 Shares of PulteGroup, Inc. (NYSE:PHM)July 14, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKMK, IHC, GBS, MRIC, and PHM Company DescriptionsGBS NYSE:GBS$2.14 +0.01 (+0.47%) As of 07/17/2025GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Independence NYSE:IHCIndependence Holding Co. engages in the provision of health, pet and life insurance business. t operates through the following segments: Specialty Health; Group Disability, Life, Short-Term Disability (DBL), and Paid Family Leave Rider (PFL); Individual Life, Annuities and Other; and Corporate. The Specialty Health segment comprises of its traditional distribution through independent agents and national accounts, and through its call centers, career advisors, generation domains, transaction websites, and legal generation company. The company was founded in 1980 and is headquartered in Stamford, CT.MRI Interventions OTCMKTS:MRICMRI Interventions, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance. It offers ClearPoint system, a neuro-navigation system designed for placing catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. The company has a strategic agreement with Voyager Therapeutics, Inc. for the neurosurgical device service, supply, and development; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB to provide navigation and laser ablation platforms for use in spine and neurosurgery. MRI Interventions, Inc. was founded in 1998 and is headquartered in Irvine, California.PulteGroup NYSE:PHM$108.72 -0.56 (-0.51%) Closing price 03:59 PM EasternExtended Trading$108.82 +0.10 (+0.09%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States. It acquires and develops land primarily for residential purposes; and constructs housing on such land. The company also offers various home designs, including single-family detached, townhomes, condominiums, and duplexes under the Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West brand names. In addition, the company arranges financing through the origination of mortgage loans primarily for homebuyers; sells the servicing rights for the originated loans; and provides title insurance policies, and examination and closing services to homebuyers. PulteGroup, Inc. was founded in 1950 and is headquartered in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
